ARCHIVES

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

In Brief: City of Hope Wins $5.5M Grant From NIA; Comis To Head Group Chairmen’s Committee

November 23, 1997

SSO Workshop Calls For Certification of Surgical Oncologists, Increased Commitments By NCI, ACS

November 18, 1983

In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership

July 10, 1992

NCI prepares for third hearing on conflicts of interest.

June 18, 2004